探索基因测试对抑郁症个性化治疗计划的影响
Shichao Li1, Liang Peng1, Yuting Wang2
1Psychiatry Department, Suizhou Hospital Affiliated to Hubei University of Medicine, 441300 Suizhou, Hubei, China.
Actas espanolas de psiquiatria
|February 27, 2026
概括
在CYP2C19的遗传变异影响塞特拉林对抑郁症的有效性. 低代谢者表现出更好的疗效,但更多的副作用,而快速代谢者表现较差. 推基于基因检测的个性化治疗.
科学领域:
- 药物基因组学 药物基因组学
- 临床药房 临床药房
- 神经科学是一个神经科学.
背景情况:
- 个体的遗传变异会影响抗抑郁药的反应.
- CYP2C19基因多态性与可变的药物代谢有关.
- 基因检测可以指导个性化抑郁症治疗.
研究的目的:
- 研究CYP2C19遗传多态性和塞特拉林疗效之间的关联.
- 评估代谢表型对抑郁症治疗结果的影响.
- 通过遗传指导,提高抗抑郁药治疗的准确性.
主要方法:
- 对202名患有CYP2C19基因的抑郁症患者进行了回顾性研究.
- 分类为快速 (A组),中等 (B组) 和低 (C组) 的代谢组.
- 用塞特拉林治疗六周,监测抑郁症得分 (HAMD,CGI-I),神经递质水平 (5-HT,GABA,BDNF) 和坚持 (MMAS-8).
主要成果:
- 与A组和B组相比,代谢较差的人 (C组) 的HAMD得分降低显著更大,反应和缓解率更高,作用开始更快.
- 组C显示5-HT,GABA和BDNF水平的增加更加明显.
- 不良事件发生率在C组 (41.9%) 中最高,在A组 (10.8%) 中最低,而B组显示出优异的药物坚持 (MMAS-8分数).
结论:
- CYP2C19代谢表型显著影响塞特拉林在抑郁症中的治疗结果.
- 基于CYP2C19代谢类型的个性化治疗策略可以优化疗效并最大限度地减少不良事件.
- 为了平衡疗效,坚持性和副作用,需要根据遗传数据进行个性化的方法.
相关概念视频
01:28Human Genetics
1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:29Pharmacogenetics and Pharmacogenomics: Overview
74
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
74
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
54
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
54
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
63
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
63
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K